Zaire Ebolavirus Glycoprotein-directed Antibody class drugs

FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

1 result

Ebanga (ansuvimab)

(ANSUVIMAB)

Manufacturer:Ridgeback Biotherapeutics, LP

Usage: EBANGA is indicated for treating infections caused by Zaire ebolavirus in adult and pediatric patients, including neonates born to RT-PCR positive mothers. Its efficacy for other Ebolavirus or Marburgvirus species is not established, and clinical benefits may diminish due to resistance or viral changes.